top of page

Vaccine Side Effects: Who Suffers Most?

From eNewsletter 3/17/2021

DID YOU KNOW that a huge, 25-year study in Neurology states higher levels of leisure-time physical activity in midlife (150 minutes per week or more) is associated with a lower risk for cerebrovascular problems such as dementia, white matter integrity, and fewer lacunar strokes in later life? Examples of leisure-time physical activity are housework, child care, or nonexercise walking. Moreover, just 10 minutes of persistent, moderate-vigorous levels of physical activity at midlife (75 total minutes weekly) was also associated with more intact white matter integrity, fewer lacunar strokes, and fewer incidents of dementia. Examples of moderate-vigorous levels of physical activity are fast walking, cycling, running, yoga, or swimming. Golf falls somewhere between leisure and moderate activity. The lack of effective pharmacologic treatments for dementia underscores the importance of physical activity, a modifiable behavior, which benefits brain health. And you can can perform at a physical activity level that works for you!

Biotrition Food Intolerance Test Blood Draw The next Biotrition Food Intolerance Test blood draw is Saturday, April 24th. Please text, email, or call us for more information.

UPDATE - COVID-19 Vaccine Information We updated this document Monday March 15th.

UPDATE - Virus Prevention And Treatment Vaccines will minimize COVID-19 related mortality and hospitalizations, but SARS-CoV-2 is not going away, as evidenced by its ever-mutating variants. Moreover, SARS-CoV-2 is not the only virus we fight. There are influenza (flu), norovirus (stomach flu), adenovirus (common cold), and four other coronaviruses (common cold), among others.We highly recommend continuing your immune support. For more information, refer to our Prevent and Fight Viruses 2.0 Protocol.

COVID-19 Condition Monograph For those interested in conventional and integrative treatments for COVID-19 with over 250 references, this is our COVID-19 Condition Monograph.

Post-COVID Syndrome The official diagnosis for post-COVID syndrome (PCS) are symptoms that last for 12 weeks or more. If you, a family member, friend, coworker, or neighbor is suffering from PCS, diligently following our Post-COVID Syndrome Action Plan for purchase, or free to paid members, can bring measurable improvement.


Steve and Bonnie: The great news is that the hospitals reporting ICUs at or above capacity has fallen by more than 50% since early January. Let's hope that the recent coronavirus variant surge ravaging Europe will not occur here.

Women Report More Severe COVID-19 Vaccine Side Effects

Similar to how women report higher incidence of pain and chronic health conditions, new research from the CDC show women reported 79% of side effects from the COVID-19 vaccines. In the small number of those reporting anaphylactic reactions, almost all were female.

Women tend to have a more robust immune system that can produce more antibodies in response to vaccines, which may be related to reproductive hormones such as estrogen and progesterone. Estrogen can cause immune cells to produce more antibodies, which is why it is protective against COVID-19 infection and why women are at less risk from infection.

CBD (Cannabidiol)

In a new study from Biorxiv, patients previously taking organic oral CBD had significantly lower SARS-CoV-2 infection incidence relative to the general population. The researchers suggest CBD could be acting to block viral entry to host cells or at later steps following infection by decreasing ACE2 expression.

Cabbage and Fermented Vegetables

Large differences in COVID‐19 death rates exist between countries and between regions of the same country. Some very low death rate countries such as Eastern Asia, Central Europe, or the Balkans have a common feature of eating large quantities of cabbage and fermented foods. Cabbage contains precursors of sulforaphane, the most active natural activator of Nrf2, which is protective against coronavirus. Fermented vegetables contain many lactobacilli, which are also potent Nrf2 activators.


A US Veteran Administration study saw reduced incidence and less severe outcomes for COVID-19 in patients treated with disulfiram compared to those not treated with it. Disulfiram is safe and effective drug used to support the treatment of chronic alcoholism. Given the known anti-inflammatory and viral anti-protease effects of disulfiram, it is reasonable to initiate accelerated clinical trials.

Planning Surgery After Having COVID-19

Seven weeks appears to be the ideal amount of time to delay surgery, when possible, after testing positive for COVID-19, according to a study in Anaesthesia.

Risk for death was about 3.5 to 4 times higher in the first 6 weeks after surgery among more than 3000 people with a preoperative COVID-19 diagnosis compared with patients without COVID-19. After 7 weeks, the 30-day mortality rate dropped to a baseline level. Surgery should be further delayed for people who remain symptomatic at 7 weeks postdiagnosis.

FDA Authorizes First Molecular At-Home, OTC COVID-19 Test

The Cue COVID-19 Test for Home and Over The Counter Use (Cue OTC Test, Cue Health Inc) is the first molecular diagnostic test available to consumers without a prescription. The test detects genetic material from SARS-CoV-2 present in the nostrils and delivers results in about 20 minutes to the user's mobile smart device via the Cue Health app.

Some Fever Scanners May Be Inaccurate

FDA has issued an alert to consumers, healthcare providers, and other users of thermal imaging systems that measure body temperature that improper use may produce inaccurate readings.

The systems may miss a key indicator of coronavirus infection, according to new research in the Journal of Biomedical Optics. The systems are known as telethermographic systems, infrared thermographs, thermal cameras, and "fever cameras." This alert does not pertain to the handheld, noncontact infrared thermometers (NCIT) used to screen individuals.

Colchicine, Convalescent Plasma, and Ivermectin

On the advice of its independent data monitoring committee (DMC), the RECOVERY trial has stopped recommending colchicine for lack of efficacy in patients hospitalized with COVID-19. Two anti-inflammatory drugs - dexamethasone and tocilizumab - have been established for improving the chances of survival for patients with severe COVID-19.

In the same RECOVERY trial, hospitals using convalescent plasma treatments have stopped, as patients treated with it have not shown improvement.

The FDA has issued guidance warning consumers against using the antiparasitic drug ivermectin to treat or prevent COVID-19. While Ivermectin has not been approved by the FDA for treating or preventing COVID-19, we disagree with this warning based upon the data that we've seen.We think it is effective.


This article is reserved for NCI Well Connect Members. You can get this article by signing up here. You can get our free eNewsletter by signing up at the top of our website.


bottom of page